Propofol Deep Sedation for RFA in Sick Elderly Patients with Hepatocellular Carcinoma
What is it about?
The aim of this study was to evaluate and compare the clinical efficacy of propofol-based deep sedation (PBDS) for percutaneous radiofrequency ablation (RFA) in sick (American Society of Anesthesiologists [ASA] physical status III-IV) and nonsick (ASA physical status I-II) elderly patients in a teaching hospital in Thailand.
Why is it important?
There were 113 elderly patients who underwent RFA procedure by using PBDS during the study period. Of these, 69 patients were in group A and 44 patients were in group B. There were no significant differences in age, gender, weight, duration of procedure, and mean dose of propofol, fentanyl, and midazolam between the two groups. All procedures in both groups were successfully completed. Overall and cardiorespiratory adverse events in both groups were not significantly different. All adverse events were easily treated, with no adverse sequelae.
The following have contributed to this page: Somchai Amornyotin